BFM
STLN

Boothbay Fund Management’s Starling Oncology STLN Stock Holding History

Boothbay Fund Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
233,379
+95,587
+69% +$402K 0.02% 961
2026
Q1 		$423K Buy
137,792
+52,562
+62% +$161K 0.01% 1431
2025
Q4 		$303K Sell
85,230
-162,654
-66% -$603K ﹤0.01% 1422
2025
Q3 		$865K Buy
+247,884
New +$849K 0.01% 895

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Boothbay Fund Management's STLN Position: Q2 2026 in Review

Boothbay Fund Management increased its Starling Oncology (STLN) stake by 69% in Q2 2026, buying an estimated $402K and bringing the position to 233,379 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #961.

Boothbay Fund Management first reported a position in STLN in Q3 2025 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Boothbay Fund Management held 233,379 shares of Starling Oncology worth $1.27M as of Q2 2026.
  • Boothbay Fund Management bought 95,587 Starling Oncology shares in Q2 2026, an estimated $402K.
  • Starling Oncology made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #961 holding.
  • Boothbay Fund Management first reported a position in Starling Oncology in Q3 2025 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.